Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
1 clinical trials · Condition
◉ Watch Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
| Record | Firm | Date |
|---|---|---|
| Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3) (NCT05359146) | University Hospital, Basel, Switzerland | 2023-03-28 |
Track Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) automatically
Every clearance here is in the API, with alerts when new ones post.